CD8A and neoplasm: TH1-type (IFN-γ–producing) CD4+ and CD8+ T-cells, which recognize tumor antigens, may play a critical role in antitumor immunity, as illustrated by adoptive transfer of T-cells into cancer-bearing recipients (4–6).